{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:57:27Z","timestamp":1773129447586,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2003,1,1]]},"DOI":"10.1038\/sj.leu.2402736","type":"journal-article","created":{"date-parts":[[2003,1,15]],"date-time":"2003-01-15T16:47:49Z","timestamp":1042649269000},"page":"138-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"17","author":[{"given":"E","family":"Bj\u00f6rklund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"S\u00f6derh\u00e4ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Porwit-MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,1,3]]},"reference":[{"key":"BF2402736_CR1","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1038\/sj.leu.2401938","volume":"14","author":"CH Pui","year":"2000","unstructured":"Pui, CH, Boyett, JM, Rivera, GK, Hancock, ML, Sandlund, JT, Ribeiro, RC, Rubnitz, JE, Behm, FG, Raimondi, SC, Gajjar, A, Razzouk, B, Campana, D, Kun, LE, Relling, MV & Evans, WE Long-term results of total therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia, (2000). 14, 2286\u20132294.","journal-title":"Leukemia"},{"key":"BF2402736_CR2","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1038\/sj.leu.2401962","volume":"14","author":"OB Eden","year":"2000","unstructured":"Eden, OB, Harrison, G, Richards, S, Lilleyman, JS, Bailey, CC, Chessells, JM, Hann, IM, Hill, FG & Gibson, BE Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980\u20131997. Medical Research Council Childhood Leukaemia Working Party. Leukemia, (2000). 14, 2307\u20132320.","journal-title":"Leukemia"},{"key":"BF2402736_CR3","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1038\/sj.leu.2401961","volume":"14","author":"G Gustafsson","year":"2000","unstructured":"Gustafsson, G, Schmiegelow, K, Forestier, E, Clausen, N, Glomstein, A, Jonmundsson, G, Mellander, L, Makipernaa, A, Nygaard, R & Saarinen-Pihkala, UM Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia, (2000). 14, 2267\u20132275.","journal-title":"Leukemia"},{"key":"BF2402736_CR4","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2401960","volume":"14","author":"E Vilmer","year":"2000","unstructured":"Vilmer, E, Suciu, S, Ferster, A, Bertrand, Y, Cave, H, Thyss, A, Benoit, Y, Dastugue, N, Fournier, M, Souillet, G, Manel, AM, Robert, A, Nelken, B, Millot, F, Lutz, P, Rialland, X, Mechinaud, F, Boutard, P, Behar, C, Chantraine, JM, Plouvier, E, Laureys, G, Brock, P, Uyttebroeck, A, Margueritte, G, Plantaz, D, Norton, L, Francotte, N, Gyselinck, J, Waterkeyn, C, Solbu, G, Philippe, N & Otten, J Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia, (2000). 14, 2257\u20132266.","journal-title":"Leukemia"},{"key":"BF2402736_CR5","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1038\/sj.leu.2401977","volume":"14","author":"M Schrappe","year":"2000","unstructured":"Schrappe, M, Camitta, B, Pui, CH, Eden, T, Gaynon, P, Gustafsson, G, Janka-Schaub, GE, Kamps, W, Masera, G, Sallan, S, Tsuchida, M & Vilmer, E Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia, (2000). 14, 2193\u20132194.","journal-title":"Leukemia"},{"key":"BF2402736_CR6","first-page":"165","volume":"39","author":"G Mathe","year":"1973","unstructured":"Mathe, G, Weiner, R, Pouillart, P, Schwarzenberg, L, Jasmin, C, Schneider, M, Hayat, M, Amiel, JL, de Vassal, F & Rosenfeld, C BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease. Natl Cancer Inst Monogr, (1973). 39, 165\u2013175.","journal-title":"Natl Cancer Inst Monogr"},{"key":"BF2402736_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/jnci\/53.2.389","volume":"53","author":"JU Gutterman","year":"1974","unstructured":"Gutterman, JU, Mavligit, G, Burgess, MA, McCredie, KB, Hunter, C, Freireich, EJ & Hersh, EM Immunodiagnosis of acute leukemia: detection of residual disease. J Natl Cancer Inst, (1974). 53, 389\u2013392.","journal-title":"J Natl Cancer Inst"},{"key":"BF2402736_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0145-2126(81)90002-3","volume":"5","author":"KF Bradstock","year":"1981","unstructured":"Bradstock, KF, Janossy, G, Tidman, N, Papageorgiou, ES, Prentice, HG, Willoughby, M & Hoffbrand, AV Immunological monitoring of residual disease in treated thymic acute lymphoblastic leukaemia. Leuk Res, (1981). 5, 301\u2013309.","journal-title":"Leuk Res"},{"key":"BF2402736_CR9","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1182\/blood.V85.6.1416.bloodjournal8561416","volume":"85","author":"D Campana","year":"1995","unstructured":"Campana, D & Pui, CH Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood, (1995). 85, 1416\u20131434.","journal-title":"Blood"},{"key":"BF2402736_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1040-8428(99)00032-3","volume":"32","author":"JF San Miguel","year":"1999","unstructured":"San Miguel, JF, Ciudad, J, Vidriales, MB, Orfao, A, Lucio, P, Porwit-MacDonald, A, Gaipa, G, van Wering, E & van Dongen, JJ Immunophenotypical detection of minimal residual disease in acute leukemia. Crit Rev Oncol Hematol, (1999). 32, 175\u2013185.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BF2402736_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1470-2045(00)00418-6","volume":"2","author":"T Szczepanski","year":"2001","unstructured":"Szczepanski, T, Orfao, A, van der Velden, VH, San Miguel, JF & van Dongen, JJ Minimal residual disease in leukaemia patients. Lancet Oncol, (2001). 2, 409\u2013417.","journal-title":"Lancet Oncol"},{"key":"BF2402736_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/978-1-4615-4811-9_40","volume":"457","author":"CH Pui","year":"1999","unstructured":"Pui, CH & Evans, WE Genetic abnormalities and drug resistance in acute lymphoblastic leukemia. Adv Exp Med Biol, (1999). 457, 383\u2013389.","journal-title":"Adv Exp Med Biol"},{"key":"BF2402736_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1034\/j.1600-0609.2000.90103.x","volume":"64","author":"E Forestier","year":"2000","unstructured":"Forestier, E, Johansson, B, Borgstrom, G, Kerndrup, G, Johansson, J & Heim, S Cytogenetic findings in a population-based series of 787 childhood acute lymphoblastic leukemias from the Nordic countries. The NOPHO Leukemia Cytogenetic Study Group. Eur J Haematol, (2000). 64, 194\u2013200.","journal-title":"Eur J Haematol"},{"key":"BF2402736_CR14","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1038\/sj.leu.2401922","volume":"14","author":"A Biondi","year":"2000","unstructured":"Biondi, A, Valsecchi, MG, Seriu, T, d'Aniello, E, Willemse, MJ, Fasching, K, Pannunzio, A, Gadner, H, Schrappe, M, Kamps, WA, Bartram, CR, van Dongen, JJ & Panzer-Grumayer, ER Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group. Leukemia, (2000). 14, 1939\u20131943.","journal-title":"Leukemia"},{"key":"BF2402736_CR15","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1182\/blood.V83.7.1892.1892","volume":"83","author":"H Cave","year":"1994","unstructured":"Cave, H, Guidal, C, Rohrlich, P, Delfau, MH, Broyart, A, Lescoeur, B, Rahimy, C, Fenneteau, O, Monplaisir, N & d'Auriol, L Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes. Blood, (1994). 83, 1892\u20131902.","journal-title":"Blood"},{"key":"BF2402736_CR16","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/sj.leu.2401801","volume":"14","author":"OJ Verhagen","year":"2000","unstructured":"Verhagen, OJ, Willemse, MJ, Breunis, WB, Wijkhuijs, AJ, Jacobs, DC, Joosten, SA, van Wering, ER, van Dongen, JJ & van der Schoot, CE Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia, (2000). 14, 1426\u20131435.","journal-title":"Leukemia"},{"key":"BF2402736_CR17","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1182\/blood.V99.6.1952","volume":"99","author":"MN Dworzak","year":"2002","unstructured":"Dworzak, MN, Froschl, G, Printz, D, Mann, G, Potschger, U, Muhlegger, N, Fritsch, G & Gadner, H Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia. Blood, (2002). 99, 1952\u20131958.","journal-title":"Blood"},{"key":"BF2402736_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/sj.leu.2402021","volume":"15","author":"D Campana","year":"2001","unstructured":"Campana, D, Neale, GA, Coustan-Smith, E & Pui, CH Detection of minimal residual disease in acute lymphoblastic leukemia: the St Jude experience. Leukemia, (2001). 15, 278\u2013279.","journal-title":"Leukemia"},{"key":"BF2402736_CR19","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1200\/JCO.1998.16.12.3774","volume":"16","author":"J Ciudad","year":"1998","unstructured":"Ciudad, J, San Miguel, JF, Lopez-Berges, MC, Vidriales, B, Valverde, B, Ocqueteau, M, Mateos, G, Caballero, MD, Hernandez, J, Moro, MJ, Mateos, MV & Orfao, A Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia. J Clin Oncol, (1998). 16, 3774\u20133781.","journal-title":"J Clin Oncol"},{"key":"BF2402736_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/(SICI)1097-0320(19971101)29:3<242::AID-CYTO7>3.0.CO;2-D","volume":"29","author":"J Philippe","year":"1997","unstructured":"Philippe, J, Louagie, H, Thierens, H, Vral, A, Cornelissen, M & De Ridder, L Quantification of apoptosis in lymphocyte subsets and effect of apoptosis on apparent expression of membrane antigens. Cytometry, (1997). 29, 242\u2013249.","journal-title":"Cytometry"},{"key":"BF2402736_CR21","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","volume":"352","author":"JJ van Dongen","year":"1998","unstructured":"van Dongen, JJ, Seriu, T, Panzer-Grumayer, ER, Biondi, A, Pongers-Willemse, MJ, Corral, L, Stolz, F, Schrappe, M, Masera, G, Kamps, WA, Gadner, H, van Wering, ER, Ludwig, WD, Basso, G, de Bruijn, MA, Cazzaniga, G, Hettinger, K, van der Does-van den Berg, A, Hop, WC, Riehm, H & Bartram, CR Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet, (1998). 352, 1731\u20131738.","journal-title":"Lancet"},{"key":"BF2402736_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJM199808273390904","volume":"339","author":"H Cave","year":"1998","unstructured":"Cave, H, van der Werff ten Bosch,, Suciu, S, Guidal, C, Waterkeyn, C, Otten, J, Bakkus, M, Thielemans, K, Grandchamp, B & Vilmer, E Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer \u2013 Childhood Leukemia Cooperative Group. N Engl J Med, (1998). 339, 591\u2013598.","journal-title":"N Engl J Med"},{"key":"BF2402736_CR23","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood.V96.8.2691","volume":"96","author":"E Coustan-Smith","year":"2000","unstructured":"Coustan-Smith, E, Sancho, J, Hancock, ML, Boyett, JM, Behm, FG, Raimondi, SC, Sandlund, JT, Rivera, GK, Rubnitz, JE, Ribeiro, RC, Pui, CH & Campana, D Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood, (2000). 96, 2691\u20132696.","journal-title":"Blood"},{"key":"BF2402736_CR24","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1182\/blood.V99.4.1253","volume":"99","author":"C Nyvold","year":"2002","unstructured":"Nyvold, C, Madsen, HO, Ryder, LP, Seyfarth, J, Svejgaard, A, Clausen, N, Wesenberg, F, Jonsson, OG, Forestier, E & Schmiegelow, K Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome. Blood, (2002). 99, 1253\u20131258.","journal-title":"Blood"},{"key":"BF2402736_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1053\/beha.2002.0184","volume":"15","author":"T Szczepanski","year":"2002","unstructured":"Szczepanski, T, Flohr, T, van der Velden, VH, Bartram, CR & van Dongen, JJ Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia. Best Pract Res Clin Haematol, (2002). 15, 37\u201357.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BF2402736_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJM199701303360501","volume":"336s","author":"WM Roberts","year":"1997","unstructured":"Roberts, WM, Estrov, Z, Ouspenskaia, MV, Johnston, DA, McClain, KL & Zipf, TF Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med, (1997). 336s, 317\u2013323.","journal-title":"N Engl J Med"},{"key":"BF2402736_CR27","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1365-2141.1995.tb05360.x","volume":"91","author":"N Farahat","year":"1995","unstructured":"Farahat, N, Lens, D, Zomas, A, Morilla, R, Matutes, E & Catovsky, D Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors. Br J Haematol, (1995). 91, 640\u2013646.","journal-title":"Br J Haematol"},{"key":"BF2402736_CR28","first-page":"305","volume":"26","author":"MN Dworzak","year":"1998","unstructured":"Dworzak, MN, Fritsch, G, Fleischer, C, Printz, D, Froschl, G, Buchinger, P, Mann, G & Gadner, H Comparative phenotype mapping of normal vs malignant pediatric B-lymphopoiesis unveils leukemia-associated aberrations. Exp Hematol, (1998). 26, 305\u2013313.","journal-title":"Exp Hematol"},{"key":"BF2402736_CR29","first-page":"1069","volume":"83","author":"J Ciudad","year":"1998","unstructured":"Ciudad, J, Orfao, A, Vidriales, B, Macedo, A, Martinez, A, Gonzalez, M, Lopez-Berges, MC, Valverde, B & San Miguel, JF Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection. Haematologica, (1998). 83, 1069\u20131075.","journal-title":"Haematologica"},{"key":"BF2402736_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/sj.leu.2401279","volume":"13","author":"P Lucio","year":"1999","unstructured":"Lucio, P, Parreira, A, van den Beemd, MW, van Lochem, EG, van Wering, ER, Baars, E, Porwit-MacDonald, A, Bjorklund, E, Gaipa, G, Biondi, A, Orfao, A, Janossy, G, van Dongen, JJ & San Miguel, JF Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia, (1999). 13, 419\u2013427.","journal-title":"Leukemia"},{"key":"BF2402736_CR31","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/sj.leu.2401364","volume":"13","author":"EG Weir","year":"1999","unstructured":"Weir, EG, Cowan, K, LeBeau, P & Borowitz, MJ A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection. Leukemia, (1999). 13, 558\u2013567.","journal-title":"Leukemia"},{"key":"BF2402736_CR32","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/sj.leu.2401741","volume":"14","author":"A Porwit-MacDonald","year":"2000","unstructured":"Porwit-MacDonald, A, Bjorklund, E, Lucio, P, van Lochem, EG, Mazur, J, Parreira, A, van den Beemd, MW, van Wering, ER, Baars, E, Gaipa, G, Biondi, A, Ciudad, J, van Dongen, JJ, San Miguel, JF & Orfao, A BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL). Leukemia, (2000). 14, 816\u2013825.","journal-title":"Leukemia"},{"key":"BF2402736_CR33","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1182\/blood.V98.8.2498","volume":"15","author":"RW McKenna","year":"2001","unstructured":"McKenna, RW, Washington, LT, Aquino, DB, Picker, LJ & Kroft, SH Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood, (2001). 15, 2498\u20132507.","journal-title":"Blood"},{"key":"BF2402736_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/cyto.990180203","volume":"18","author":"D Campana","year":"1994","unstructured":"Campana, D Applications of cytometry to study acute leukemia: in vitro determination of drug sensitivity and detection of minimal residual disease. Cytometry, (1994). 18, 68\u201374.","journal-title":"Cytometry"},{"key":"BF2402736_CR35","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0140-6736(97)10295-1","volume":"351","author":"E Coustan-Smith","year":"1998","unstructured":"Coustan-Smith, E, Behm, FG, Sanchez, J, Boyett, JM, Hancock, ML, Raimondi, SC, Rubnitz, JE, Rivera, GK, Sandlund, JT, Pui, CH & Campana, D Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet, (1998). 351, 550\u2013554.","journal-title":"Lancet"},{"key":"BF2402736_CR36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","volume":"33","author":"JM Bennett","year":"1976","unstructured":"Bennett, JM, Catovsky, D, Daniel, MT, Flandrin, G, Galton, DA, Gralnick, HR & Sultan, C Proposals for the classification of the acute leukaemias. French\u2013American\u2013British (FAB) co-operative group. Br J Haematol, (1976). 33, 451\u2013458.","journal-title":"Br J Haematol"},{"key":"BF2402736_CR37","first-page":"1783","volume":"9","author":"MC Bene","year":"1995","unstructured":"Bene, MC, Castoldi, G, Knapp, W, Ludwig, WD, Matutes, E, Orfao, A & van't Veer, MB Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia, (1995). 9, 1783\u20131786.","journal-title":"Leukemia"},{"key":"BF2402736_CR38","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.1651-2227.1998.tb00923.x","volume":"87","author":"G Gustafsson","year":"1998","unstructured":"Gustafsson, G, Kreuger, A, Clausen, N, Garwicz, S, Kristinsson, J, Lie, SO, Moe, PJ, Perkkio, M, Yssing, M & Saarinen-Pihkala, UM Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO). Acta Paediatr, (1998). 87, 1151\u20131161.","journal-title":"Acta Paediatr"},{"key":"BF2402736_CR39","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/sj.leu.2402150","volume":"15","author":"P Lucio","year":"2001","unstructured":"Lucio, P, Gaipa, G, van Lochem, EG, van Wering, ER, Porwit-MacDonald, A, Faria, T, Bjorklund, E, Biondi, A, van den Beemd, MW, Baars, E, Vidriales, B, Parreira, A, van Dongen, JJ, San Miguel, JF & Orfao, A BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation. Leukemia, (2001). 15, 1185\u20131192.","journal-title":"Leukemia"},{"key":"BF2402736_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/(SICI)1097-0320(19990815)38:4<139::AID-CYTO1>3.0.CO;2-H","volume":"38","author":"D Campana","year":"1999","unstructured":"Campana, D & Coustan-Smith, E Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry, (1999). 38, 139\u2013152.","journal-title":"Cytometry"},{"key":"BF2402736_CR41","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/sj.leu.2402091","volume":"15","author":"M Malec","year":"2001","unstructured":"Malec, M, Bjorklund, E, Soderhall, S, Mazur, J, Sjogren, AM, Pisa, P, Bjorkholm, M & Porwit-MacDonald, A Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL. Leukemia, (2001). 15, 716\u2013727.","journal-title":"Leukemia"},{"key":"BF2402736_CR42","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/sj.leu.2401459","volume":"13","author":"GA Neale","year":"1999","unstructured":"Neale, GA, Coustan-Smith, E, Pan, Q, Chen, X, Gruhn, B, Stow, P, Behm, FG, Pui, CH & Campana, D Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia, (1999). 13, 1221\u20131226.","journal-title":"Leukemia"},{"key":"BF2402736_CR43","first-page":"1523","volume":"9","author":"ER van Wering","year":"1995","unstructured":"van Wering, ER, Beishuizen, A, Roeffen, ET, van der Linden-Schrever, BE, Verhoeven, MA, Hahlen, K, Hooijkaas, H & van Dongen, JJ Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia. Leukemia, (1995). 9, 1523\u20131533.","journal-title":"Leukemia"},{"key":"BF2402736_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/jcp.49.1.15","volume":"49","author":"A Macedo","year":"1996","unstructured":"Macedo, A, San Miguel, JF, Vidriales, MB, Lopez-Berges, MC, Garcia-Marcos, MA, Gonzalez, M, Landolfi, C & Orfao, A Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease. J Clin Pathol, (1996). 49, 15\u201318.","journal-title":"J Clin Pathol"},{"key":"BF2402736_CR45","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1046\/j.1365-2141.1999.01236.x","volume":"104","author":"J Ciudad","year":"1999","unstructured":"Ciudad, J, San Miguel, JF, Lopez-Berges, MC, Garcia, MM, Gonzalez, M, Vazquez, L, del Canizo, MC, Lopez, A, van Dongen, JJ & Orfao, A Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL. Br J Haematol, (1999). 104, 695\u2013705.","journal-title":"Br J Haematol"},{"key":"BF2402736_CR46","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/sj.leu.2401780","volume":"14","author":"CH Pui","year":"2000","unstructured":"Pui, CH & Campana, D New definition of remission in childhood acute lymphoblastic leukemia. Leukemia, (2000). 14, 783\u2013785.","journal-title":"Leukemia"},{"key":"BF2402736_CR47","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1038\/sj.leu.2400841","volume":"11","author":"L Foroni","year":"1997","unstructured":"Foroni, L, Coyle, LA, Papaioannou, M, Yaxley, JC, Sinclair, MF, Chim, JS, Cannell, P, Secker-Walker, LM, Mehta, AB, Prentice, HG & Hoffbrand, AV Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response. Leukemia, (1997). 11, 1732\u20131741.","journal-title":"Leukemia"},{"key":"BF2402736_CR48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/sj.leu.2401970","volume":"15","author":"V de Haas","year":"2001","unstructured":"de Haas, V, Verhagen, OJ, von dem, B, Kroes, W, van den Berg, H & van der Schoot, CE Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy. Leukemia, (2001). 15, 134\u2013140.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402736.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402736","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402736.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:10:14Z","timestamp":1648761014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1,1]]}},"alternative-id":["BF2402736"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402736","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,1]]},"assertion":[{"value":"7 November 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}